Skincare brands, formulators, and OEM/ODM teams
Skincare Formulation Planning With Peptide Ingredients
Use this page when your team is comparing peptide options for skincare formulas and needs a practical path from ingredient education to product inquiry, files, samples, MOQ, and pricing.
What Buyers Review
Questions this scenario usually raises.
Keep the focus on evaluation, document needs, and likely product fit.
What files or samples are needed before a commercial discussion?
Which claims should remain cosmetic, cautious, and documentation-led?
What To Compare
What buyers usually want to confirm next.
Use this page to move from scenario review into product selection and follow-up.
Start with related ingredient education, then move to product pages for procurement details.
Review COA, SDS, specification, sample availability, MOQ, and lead time before shortlisting.
Use formulation project support if the request covers multiple ingredients or a finished concept.
Formulation & Technical Video Briefs
Technical Video Briefs for Skincare Formulation
Watch ingredient specification, dispersion, transdermal delivery, and reference formulation study walkthroughs relevant to this application scenario.
On-Site Documentary · Taicang, Suzhou · 2:55
Suzhou Xilin Biotechnology (苏州汐霖生物科技有限公司): R&D, Cleanroom Production & Founder Profile
Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.
Key Verifiable Points & Parameters
- Entity & Location: 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.), founded in 2021 in Taicang, Suzhou, Jiangsu, China.
- Founder & R&D Leadership: Dr. Yiqiong Ji (纪艺琼 / Dr. Kee), with 20 years of research experience in nanomedicine and transdermal active-ingredient delivery across the skin barrier.
- Cleanroom & Equipment: 600 m² of controlled cleanroom production space, laminar flow benches, overhead formulation mixers, stainless-steel cosmetic emulsifying/homogenizing reactors, packaging lines, and warehouse dispatch.
- Facility Scope: Covers cosmetic formulation R&D, transdermal delivery systems, and ISO 22716 cosmetic GMP production at Suzhou Xilin.
Read Verbatim Transcript, Summary & Verification Scope
Summary:Documentary profile of 苏州汐霖生物科技有限公司 (Suzhou Xilin Biotechnology Co., Ltd.) in Taicang Port, Suzhou — the company whose main international peptide trade website is WUMO Peptide (peptide.wumolab.com). Founder Dr. Yiqiong Ji (纪艺琼 / Dr. Kee, formerly with the Chinese Academy of Sciences) discusses 20 years of nanomedicine and transdermal active-delivery research, the 600 m² cleanroom production base, cosmetic emulsification reactors, and traceable OEM/ODM manufacturing.
Verbatim Audio / Visual Transcript:Narrator: At Taicang Port (太仓港区), an entrepreneur with a research background at the Chinese Academy of Sciences spent 20 years studying how to improve the delivery of active ingredients across the skin barrier. Then came another four years of turning that research into a real business. Title card: How many skin barriers must skincare ingredients penetrate to be fully absorbed? Dr. Yiqiong Ji (纪艺琼, Founder of 苏州汐霖生物科技有限公司 / Suzhou Xilin Biotechnology Co., Ltd.): "My name is Yiqiong Ji. I founded Suzhou Xilin Biotech in Taicang in 2021. My background is nanomedicine delivery research, essentially helping active ingredients work where they are needed. We apply this knowledge to cosmetics, improving skincare active delivery. Our facility includes 600 m² of cleanroom space, ensuring traceability. Brands choose us for our technical capabilities. For a tech-driven team, R&D, production, and market opening are challenges." Partner commentary: "Support, like a well-designed delivery system, works quietly beneath the surface. We want to be a dependable partner to growing businesses. Ms. Ji’s team remains focused on technology and approaches its work with discipline. Through professional and efficient financial services, we help them concentrate on R&D and production. This gives the company greater stability and confidence as it grows." Dr. Yiqiong Ji: "Our goal is to make advanced technology accessible, enabling brands to benefit from high-quality R&D. Quality, reliable performance, and accessible pricing are our focus. Last year, we successfully launched a cream featuring hydroxypropyl tetrahydropyrantriol (Pro-Xylane) and other products, which were well received. This year we aim to integrate new technologies and ideas for stronger product performance." Partner commentary: "Taicang Port is home to many technology-driven companies like Suzhou Xilin Biotech. They stay focused, develop their expertise, and grow steadily." Dr. Yiqiong Ji: "We are planning our layered Precision Age Care series using a layer-specific skincare approach. It combines our delivery technology with actives to address various signs of aging and skin needs. This multi-level system targets hydration, barrier care, firmness, elasticity, and smoother skin. Each formula addresses a defined concern, reflecting our core principle: precision in formulation design and active ingredient delivery." Narrator: "Research and company building take time, but with sound technology and reliable materials, their value becomes visible."
Editorial & Verification Scope Note:Note on AI English dubbing captions: The video’s burned-in English captions phonetically render 太仓 (Taicang) as "Tai Cheng / Taichung" and 汐霖 (Xilin) as "Silan / Xylan Biotech". The on-screen Chinese signage at 01:04 shows the official registered name: 苏州汐霖生物科技有限公司 (SUZHOU XILIN BIOTECHNOLOGY CO., LTD).
Ingredient & Study Brief · CAS 89030-95-5 · 1:00
GHK-Cu (Copper Tripeptide-1): Molecular Identity, HPLC/MS Checks & 56-Day Reference Formula Study
Technical overview of Copper Tripeptide-1 (GHK-Cu, CAS 89030-95-5): glycyl-L-histidyl-L-lysine copper complex structure, characteristic blue crystalline powder appearance, supplier mass spectrometry (MS) and HPLC identity/purity verification, in-vitro cell scratch migration assay, and a 56-day reference facial formula study on 36 adults.
Key Verifiable Points & Parameters
- Identity: INCI Copper Tripeptide-1 (GHK-Cu, commonly referenced as CAS 89030-95-5, C14H22N6O4Cu) — complex of tripeptide GHK with a copper(II) ion, presenting as a characteristic blue powder.
- Analytical Documentation: Batch identity and purity are verified through mass spectrometry (MS) and HPLC chromatographic records.
- In-Vitro Cell Scratch Assay (Supplier Data): Tested concentrations showed +67% and +105% higher cell migration relative to control in a laboratory scratch model.
- 56-Day Topical Reference Study (n = 36 adults): Using a 0.2% reference copper peptide facial formula twice daily for 56 days, supplier data reported -25.96% wrinkle volume and +21.65% immediate elasticity vs baseline.
Read Verbatim Transcript, Summary & Verification Scope
Summary:Technical overview of Copper Tripeptide-1 (GHK-Cu, CAS 89030-95-5): glycyl-L-histidyl-L-lysine copper complex structure, characteristic blue crystalline powder appearance, supplier mass spectrometry (MS) and HPLC identity/purity verification, in-vitro cell scratch migration assay, and a 56-day reference facial formula study on 36 adults.
Verbatim Audio / Visual Transcript:Meet GHK-Cu, known in cosmetics as Copper Tripeptide-1. This distinctive blue ingredient combines the tripeptide GHK with a copper ion. Supplier mass spectrum and HPLC records help document sample identity and purity. In a cell scratch assay, tested concentrations showed higher migration than control (+67% and +105% vs control). These are laboratory findings. A separate 56-day facial product study followed 36 adults using a formula with 0.2% reference copper peptide complex twice daily. At day 56, the supplier reported 25.96% lower wrinkle volume and 21.65% higher immediate elasticity versus baseline for that formula. Explore Copper Tripeptide-1 for skincare designed to improve the appearance of fine lines. For cosmetic formulation development.
Editorial & Verification Scope Note:Cell scratch and 56-day topical study figures represent supplier-reported laboratory and reference-formula data (0.2% reference copper peptide formula, n = 36) for cosmetic formulation context only. Any third-party trade names appearing in literature or reference charts remain the property of their respective owners. Confirm batch-specific COA, HPLC purity, MS identity, and copper content on your quoted WUMO batch before ordering.
Specification & Formulation Brief · CAS 616204-22-9 · 0:55
Acetyl Hexapeptide-8 (CAS 616204-22-9): Raw Material Specifications, Water Solubility & 56-Day Study
Specification and formulation walkthrough for Acetyl Hexapeptide-8 (CAS 616204-22-9, MW 889.01): aqueous dissolution demonstration, typical raw-material specification parameters (Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Solubility ≥5 mg/mL in H2O), recommended formulation range (100–1,000 ppm, pH 3–8), and 56-day topical test solution study on 17 women.
Key Verifiable Points & Parameters
- Identity & Analytical Specs: INCI Acetyl Hexapeptide-8, CAS 616204-22-9, Molecular Weight 889.01 Da, Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Aqueous Solubility ≥5 mg/mL (H2O).
- Formulation Guidelines: Water-soluble white to off-white powder; suggested use level 100–1,000 ppm (0.01%–0.1%) at formulation pH 3–8; store cool and dry (-5 to 8 °C, 2-year shelf life).
- 56-Day Topical Study (n = 17 women): Using a 0.05% (500 ppm) test solution twice daily across Day 0, 14, 28, and 56.
- Measured Day 56 Outcomes vs Baseline: Facial line volume -21.92% and facial line area -21.51% in the supplier-recorded topical study.
Read Verbatim Transcript, Summary & Verification Scope
Summary:Specification and formulation walkthrough for Acetyl Hexapeptide-8 (CAS 616204-22-9, MW 889.01): aqueous dissolution demonstration, typical raw-material specification parameters (Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Solubility ≥5 mg/mL in H2O), recommended formulation range (100–1,000 ppm, pH 3–8), and 56-day topical test solution study on 17 women.
Verbatim Audio / Visual Transcript:Meet Acetyl Hexapeptide-8, a cosmetic peptide for fine-line care. This water-soluble ingredient is designed for topical skincare formulas. Specification summary: INCI Acetyl Hexapeptide-8, CAS No. 616204-22-9, Appearance white to off-white powder, Mass spec MW 889.01, Purity ≥98.0%, Water ≤7.0%, Acetate ≤15.0%, Solubility ≥5 mg/ml (H2O), Pack size 1–500g, Storage cool and dry (-5 to 8 °C), Shelf life 2 years. The supplier suggests 100 to 1,000 parts per million, with a formulation pH between 3 and 8. In one supplier-recorded study, 17 women used a 0.05% test solution twice daily for 56 days. By day 56, measured facial line volume was 21.92% lower, and line area was 21.51% lower than baseline. Explore Acetyl Hexapeptide-8 for skincare designed to improve the appearance of fine lines. For cosmetic formulation development.
Editorial & Verification Scope Note:Note: In the first 2 seconds of the video, the automated voiceover/caption mispronounces "Acetyl Hexapeptide-8" as "Axonyl Hexapeptide-8"; the on-screen specification table at 00:06 correctly lists INCI: Acetyl Hexapeptide-8 (CAS 616204-22-9). Study figures reflect supplier-reported topical test solution data (0.05%, n = 17) for cosmetic formulation development only.
Delivery System Brief · Acetyl Hexapeptide-8 · 1:20
AHPX+ (Acetyl Hexapeptide-8 + Hydrolyzed Chitosan Carrier): Penetration & 28-Day Split-Face Study
Technical briefing on AHPX+ (patent-pending carrier CN120248173A), a 1,000 ppm cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study at Guangzhou Quality Supervision & Testing Institute on 33 adults using a 1% AHPX+ cream (-38.49% crow’s-feet volume, -30.4% length, +17.46% / ~17.6% R2 elasticity vs baseline).
Key Verifiable Points & Parameters
- Delivery Architecture: Pairs Acetyl Hexapeptide-8 with a patent-pending hydrolyzed chitosan carrier (CN120248173A) designed to improve hydrophilic peptide transport across the stratum corneum.
- Preclinical Fluorescence Penetration (Mouse Skin Model): Carrier formula showed +82% higher relative fluorescence at 2 hours and +219% (3.19×) higher at 8 hours compared with Acetyl Hexapeptide-8 alone.
- 28-Day Split-Face Study Design (GQI, n = 33): 33 adult volunteers comparing a cream containing 1% AHPX+ against a comparator cream from Day 0 to Day 28.
- Measured Day 28 Split-Face Outcomes: Crow’s-feet volume decreased by 38.49%, length decreased by 30.4%, and the Cutometer R2 gross elasticity parameter increased by 17.46% (~17.6% rounded in video) vs baseline on the 1% AHPX+ side.
Read Verbatim Transcript, Summary & Verification Scope
Summary:Technical briefing on AHPX+ (patent-pending carrier CN120248173A), a 1,000 ppm cosmetic delivery system pairing Acetyl Hexapeptide-8 with a hydrolyzed chitosan carrier to enhance transdermal uptake. Reviews preclinical mouse-skin fluorescence penetration (+82% at 2 h, +219% at 8 h vs peptide alone) and a 28-day split-face study at Guangzhou Quality Supervision & Testing Institute on 33 adults using a 1% AHPX+ cream (-38.49% crow’s-feet volume, -30.4% length, +17.46% / ~17.6% R2 elasticity vs baseline).
Verbatim Audio / Visual Transcript:Meet AHPX+, a cosmetic ingredient system built around Acetyl Hexapeptide-8. Computational screening helped guide peptide selection. The selected peptide is paired with a hydrolyzed chitosan carrier. In a mouse skin model, the carrier formula showed higher relative fluorescence than the peptide alone at 2 and 8 hours (+82% at 2 h and +219% at 8 h vs peptide alone; supplier-reported preclinical data). Laboratory assays also explored the peptide’s molecular interactions. The supplier then conducted a 28-day half-face study with 33 adults comparing a cream containing 1% AHPX+ with a comparator cream. At day 28, measured crow’s-feet length fell 30.4%, while the R2 elasticity parameter rose 17.6% from baseline on the AHPX+ side. Explore AHPX+ for skincare designed to improve the appearance of fine lines and firmness. For cosmetic formulation development.
Editorial & Verification Scope Note:Preclinical fluorescence penetration and 28-day split-face figures reflect data for the tested 1% AHPX+ carrier formulation (n = 33, Guangzhou Quality Supervision & Testing Institute). Confirm whether your inquiry requires neat Acetyl Hexapeptide-8 powder (CAS 616204-22-9) or the 1,000 ppm AHPX+ carrier complex when requesting specifications and samples.
Relevant Products
Relevant peptide directions for this scenario.
Open a product page when you need specifications, document support, or sample discussion for this scenario.
AHPX+ Modified-Chitosan Hexapeptide (1,000 ppm)
Review specifications, document support, and next-step options for this ingredient or category.
WUMO PDRN+™ Transdermal Chitosan-PDRN Complex
Review specifications, document support, and next-step options for this ingredient or category.
WUMO OatCalm+™ Supercritical Oat Alkaloids (≥12% HPLC)
Review specifications, document support, and next-step options for this ingredient or category.
Finished Formulation Concepts
Review specifications, document support, and next-step options for this ingredient or category.
Laboratory Evidence & Turnkey ODM
Quantitative Bio-Delivery Dossiers for Skincare Formulation Teams
Inspect instrumental permeation benchmarks, SEM/confocal laboratory plates, and ISO 22716 ODM architectures supporting this skincare scenario.
WUMO PDRN+™ · 188.0 nm
Transdermal Nano-PDRN Platform
+494.44% 4h ex vivo porcine skin Raman permeation, +260% 8h dermal fluorescence, and +22.91% EdU proliferation.
WUMO OatCalm+™ · ≥12% HPLC
Supercritical Oat Alkaloids
>3× anti-inflammatory cytokine suppression, TRPV1 neuro-calming, Claudin-1 restoration, and DNFB soothing histology.
AHPX+ & ISO 22716 ODM
Pro-Peptide Hub & Smart ODM
30 ppm targeted AHPX+ dosing, clear-turning hydrogel masks, and capsule creams.